Cargando…
Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503694/ https://www.ncbi.nlm.nih.gov/pubmed/37708458 http://dx.doi.org/10.1097/HC9.0000000000000282 |
| _version_ | 1785106574244577280 |
|---|---|
| author | Moon, Andrew M. Yanagihara, Ted K. Tepper, Joel E. Gerber, David A. |
| author_facet | Moon, Andrew M. Yanagihara, Ted K. Tepper, Joel E. Gerber, David A. |
| author_sort | Moon, Andrew M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10503694 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105036942023-09-16 Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC Moon, Andrew M. Yanagihara, Ted K. Tepper, Joel E. Gerber, David A. Hepatol Commun Correspondence Lippincott Williams & Wilkins 2023-09-15 /pmc/articles/PMC10503694/ /pubmed/37708458 http://dx.doi.org/10.1097/HC9.0000000000000282 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Moon, Andrew M. Yanagihara, Ted K. Tepper, Joel E. Gerber, David A. Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC |
| title | Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC |
| title_full | Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC |
| title_fullStr | Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC |
| title_full_unstemmed | Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC |
| title_short | Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC |
| title_sort | reply : understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage hcc |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503694/ https://www.ncbi.nlm.nih.gov/pubmed/37708458 http://dx.doi.org/10.1097/HC9.0000000000000282 |
| work_keys_str_mv | AT moonandrewm replyunderstandingsurvivalcomparisonsinnonrandomizedtreatmentcomparisonsforpatientswithearlystagehcc AT yanagiharatedk replyunderstandingsurvivalcomparisonsinnonrandomizedtreatmentcomparisonsforpatientswithearlystagehcc AT tepperjoele replyunderstandingsurvivalcomparisonsinnonrandomizedtreatmentcomparisonsforpatientswithearlystagehcc AT gerberdavida replyunderstandingsurvivalcomparisonsinnonrandomizedtreatmentcomparisonsforpatientswithearlystagehcc |